MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
16 nov. 2020 12h00 HE | Meridian Bioscience Inc.
CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
13 nov. 2020 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020. ...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020
20 oct. 2020 11h00 HE | Meridian Bioscience Inc.
CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics
07 oct. 2020 09h00 HE | Meridian Bioscience Inc.
CINCINNATI, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...
MBI_Logo_Tagline_Blue.jpg
Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples
14 sept. 2020 10h00 HE | Meridian Bioscience Inc.
CINCINNATI, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science critical raw materials, is pleased to...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference
31 août 2020 08h00 HE | Meridian Bioscience Inc.
CINCINNATI, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance
07 août 2020 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Announces New Board Member - Anthony Bihl
28 juil. 2020 09h00 HE | Meridian Bioscience Inc.
CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020
16 juil. 2020 09h00 HE | Meridian Bioscience Inc.
CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays
13 juil. 2020 13h00 HE | Meridian Bioscience Inc.
CINCINNATI, July 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...